Jubilant Ingrevia's Stock Sees 5.35% Increase, Outperforms Sector and Sensex.

Jubilant Ingrevia, a midcap pharmaceutical company, saw a 5.35% increase in its stock price on August 7th, 2024. This gain was reflected in the stock call given by MarketsMOJO, which rated the stock as 'Hold'.

The stock is currently trading close to its 52-week high, with only a 2.37% difference. It has also outperformed the sector by 3.01% and has shown a trend reversal after two consecutive days of falling. On the day of the gain, the stock reached an intraday high of Rs 637.95, a 5.36% increase from the previous day's close.

Jubilant Ingrevia's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.

In comparison to the Sensex, Jubilant Ingrevia's stock has performed significantly better, with a 1-day performance of 5.98% compared to Sensex's 0.79%. In the past month, the stock has shown a 19.65% increase, while the Sensex has seen a -0.98% decrease.

Overall, Jubilant Ingrevia's stock has shown a strong performance in the market, with positive gains and outperforming the sector and Sensex. Investors may want to keep an eye on this midcap pharmaceutical company as it continues to show promising growth.